Stay updated with breaking news from Skye Bioscience Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cantor Fitzgerald started coverage on shares of Skye Bioscience (NASDAQ:SKYE – Free Report) in a research report released on Thursday, Marketbeat reports. The brokerage issued an overweight rating and a $21.00 price target on the stock. SKYE has been the subject of a number of other research reports. Piper Sandler reissued an overweight rating and […]
Skye Bioscience (NASDAQ:SKYE – Get Free Report) is one of 1,000 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it compare to its competitors? We will compare Skye Bioscience to similar companies based on the strength of its profitability, dividends, risk, earnings, valuation, institutional ownership and analyst recommendations. Valuation & Earnings This table […]
Skye Bioscience (NASDAQ:SKYE – Get Free Report) is one of 992 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it contrast to its competitors? We will compare Skye Bioscience to similar companies based on the strength of its valuation, institutional ownership, dividends, analyst recommendations, risk, profitability and earnings. Insider & Institutional Ownership 21.1% […]
SKYE BIOSCIENCE, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS ...